Anemia in patients ≥75 years with metastatic clear cell renal cell carcinoma: An important poor prognostic factor in the international metastatic renal cell carcinoma database consortium model
Abstract:Background
Due to an increase in life expectancy, the incidence of metastatic renal cell carcinoma (mRCC) in patients aged ≥75 years has been increasing. In this study we investigated the characteristics before treatment and the outcomes of systemic therapies for patients aged ≥75 years with mRCC and compared the results with those for patients aged <75years in order to determine whether differences in age influenced survival.
Methods
A total of 206 consecutive Japanese patients with mRCC, including 47 pati… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.